A Study to Investigate the Effect of a New Postural Bio-feedback Device on Low Back Pain
This study is ongoing, but not recruiting participants.
Sponsor:
Pro-Active Medical Pty Ltd
Collaborator:
Department of Business and Innovation, Victoria, Australia
Information provided by (Responsible Party):
Pro-Active Medical Pty Ltd
ClinicalTrials.gov Identifier:
NCT01572779
First received: June 7, 2011
Last updated: May 26, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A postural bio-feedback device worn by subjects for 4-10 hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group. The device records movement and muscle activity data relating to the lower back. Bio-feedback is delivered to the subject as an audible tone, visual cue or vibration and aims to prompt the subject to alter their posture or position in line with recommendations given by the treating practitioner. Four small sensors are adhered to the lower back and send data wirelessly to a data logger carried in the pocket by the subject (the size of a small mobile phone).
| Condition | Intervention | Phase |
|---|---|---|
|
Low Back Pain |
Device: BSM device with bio-feedback Device: BSM device with no bio-feedback |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Multicentre, Cluster Randomised, Placebo-controlled, Open-label Pilot Study of Back Strain Monitor (BSM) With Feedback Compared With the BSM Without Feedback in Subjects With Moderate Lower Back Pain. |
Resource links provided by NLM:
Further study details as provided by Pro-Active Medical Pty Ltd:
Primary Outcome Measures:
- Roland Morris Disability Questionaire (RMDQ-23) [ Time Frame: over 12 months ] [ Designated as safety issue: No ]Functional Outcome measure
- Patient Specific Functional Scale (PSFS) [ Time Frame: over 12 months ] [ Designated as safety issue: No ]Functional Outcome Measure
- Quadruple Visual Analogue Scale (QVAS) [ Time Frame: over 12 months ] [ Designated as safety issue: No ]Pain Scale
Secondary Outcome Measures:
- The change over time from baseline in the range of movement, recorded by the device. Measured in degrees of movement in the three anatomical planes. [ Time Frame: over 12 months ] [ Designated as safety issue: No ]Functional Outcome Measure
| Estimated Enrollment: | 96 |
| Study Start Date: | November 2009 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Intervention
BSM device with bio-feedback
|
Device: BSM device with bio-feedback
A postural bio-feedback device worn by subjects for 4-10hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group. The device records movement and muscle activity data relating to the lower back. Bio-feedback is delivered to the subject as an audible tone, visual cue or vibration and aims to prompt the subject to alter their posture or position in line with recommendations given by the treating practitioner. Four small sensors are adhered to the lower back and send data wirelessly to a data logger carried in the pocket by the subject (the size of a small mobile phone).
Other Name: ViMove
|
|
Placebo Comparator: Control
The BSM device without feed-back
|
Device: BSM device with no bio-feedback
The BSM device is worn as a placebo with no bio-feedback given to the subject. The subjects in the control group wear the device for 4-10 hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group.
Other Name: ViMove with no Feedback
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Subject provides informed consent
- Age between 18 and 65 years of age
- At least moderate intensity low back pain (LBP) and/or back related leg pain, as defined by a QVAS score > 3 (Carragee, Spine 2000).
- Initial QVAS score of > 3 out of 10
- Subjects must be assessed by the practitioner as Sub Acute (3 to 12 weeks post onset of low back pain (LBP) or Chronic (> 12 weeks post onset of low back pain (LBP).
Exclusion Criteria:
- Lower back surgery within previous twelve (12) months.
- Females who are pregnant.
- Subjects with a severe hearing impairment.
- Evidence of non mechanical contributing cause for lower back pain e.g. neoplasm, infection, fracture, inflammatory disorder.
- Preceding chronic neurological changes (Sub Acute group only).
- Implanted medical device (spinal cord stimulator, intrathecal pump or peripheral nerve stimulator)
- Nerve block, spinal injection or anesthetic procedure for the treatment of lower back pain within 12 months of the study.
- Significant medical abnormalities or conditions that in the opinion of the Practitioner would interfere either with the ability to complete the study or the evaluation of the investigational device's safety and efficacy.
- Recent history of a significant medical-surgical intervention that in the judgment of the Practitioner would interfere either with the ability to complete the study or the evaluation of the investigative device's safety and efficacy.
- Known allergic skin reaction to tapes and plasters.
- Subject who is currently enrolled in an investigational drug or device study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01572779
Locations
| Australia, Victoria | |
| Metro Spinal Clinic | |
| Caulfield, Victoria, Australia, 3162 | |
| Stanlake Specialist Centre | |
| Footscray, Victoria, Australia, 3011 | |
| Myers Street Family Medical | |
| Geelong, Victoria, Australia, 3220 | |
| Peak Musculoskeletal | |
| Hampton, Victoria, Australia, 3188 | |
| Austin Hopsital | |
| Heidelberg, Victoria, Australia, 3084 | |
| Olympic Park Sports Medicine Centre | |
| Melbourne, Victoria, Australia, 3003 | |
| Epworth Hospital Richmond | |
| Richmond, Victoria, Australia, 3121 | |
| Bounce Health Group | |
| Ringwood, Victoria, Australia, 3084 | |
| The Clinic Werribee | |
| Werribee, Victoria, Australia, 3030 | |
Sponsors and Collaborators
Pro-Active Medical Pty Ltd
Department of Business and Innovation, Victoria, Australia
Investigators
| Principal Investigator: | Steven Jensen, MB BS FAFMM | Stanlake Specialist Centre |
| Principal Investigator: | Adrian Jury, MD | Myers Street Family Medical |
| Principal Investigator: | Joe Garra, MD | The Clinic Werribee |
| Principal Investigator: | Peter Braun, MD | Stanlake Specialist Centre |
| Principal Investigator: | Robert Laird | Austin Hospital Pysiotherapy Outpatients |
More Information
Additional Information:
No publications provided
| Responsible Party: | Pro-Active Medical Pty Ltd |
| ClinicalTrials.gov Identifier: | NCT01572779 History of Changes |
| Other Study ID Numbers: | ProA-BSM-001 |
| Study First Received: | June 7, 2011 |
| Last Updated: | May 26, 2013 |
| Health Authority: | Australia: Department of Health and Ageing Therapeutic Goods Administration |
Keywords provided by Pro-Active Medical Pty Ltd:
|
dorsavi vimove biofeedback objective movement data back pain |
Additional relevant MeSH terms:
|
Back Pain Low Back Pain Pain |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on June 13, 2013